Dasantafil

DB19918ExperimentalSmall molecule

Dasantafil is a small molecule drug. The usage of the INN stem '-afil' in the name indicates that Dasantafil is a inhibitor of phosphodiesterase PDE5 with vasodilator action. Dasantafil has... Dasantafil has a monoisotopic molecular weight of 521.13 Da.

Formula / weight: C₂₂H₂₈BrN₅O₅ · 522.4 g/mol (avg)
Code names: SCH-446132

Resolves to

Compound

UNII48P711MI2GCAS569351-91-3ChEMBLCHEMBL2107326ChEBI752570PubChem9871410

Structure

InChIKeyRCJYGWGQCPDYSL-HZPDHXFCSA-NSMILESCCN1C(=O)N(CCO)C2=C(N(CC3=CC(Br)=C(OC)C=C3)C(N[C@@H]3CCC[C@H]3O)=N2)C1=O

Targets

O76074PDE5A

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Dasantafil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account